Madison Investment Advisors’s Quest Diagnostics DGX Stock Holding History

Madison Investment Advisors’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$1.18M	Buy	+7,817	New	+$1.22M	0.01%	275

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Madison Investment Advisors's DGX Position: Q4 2024 in Review

Madison Investment Advisors opened a new position in Quest Diagnostics (DGX) in Q4 2024: 7,817 shares worth $1.18M. The stake represents 0.01% of the portfolio and ranks #275 among its holdings.

897 funds tracked by Wall St. Rank hold DGX as of Q4 2024.

Madison Investment Advisors held 7,817 shares of Quest Diagnostics worth $1.18M as of Q4 2024.
Quest Diagnostics was a new Madison Investment Advisors position in Q4 2024.
Quest Diagnostics made up 0.01% of Madison Investment Advisors's portfolio in Q4 2024, its #275 holding.
897 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2024.

Based on Madison Investment Advisors's 13F filing for Q4 2024, filed 10 Feb 2025.